| Host: |
HEK293 cells |
| Reactivity: |
Human |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Active Recombinant-Human FcRn-C-His (FCGRT) &No tag (B2M) protein was developed from hek293 cells and has a target region of C-His (FCGRT) &No tag (B2M). For use in research applications. |
| Formulation: |
Lyophilized from a 0.22 Mu m filtered solution of PBS, pH 7.4. Contact us for customized product form or formulation. |
| Immunoreactivity: |
Measured by its binding ability in a functional ELISA. Immobilized Human FCGRT&B2M at 5 Mu g/mL (100 Mu L/well) can bind biotinylated human IgG1 with a linear range of 1-6 Mu g/mL.2. Immobilized Trastuzumab on COOH Chip can bind Human FCGRT&B2M Heter |
| Immunogen Region: |
Ile21-Met119 |
| Immunogen: |
Recombinant Human FcRn Protein is produced by HEK293 cells expression system. The target heterodimer proteins are co-expressed with the sequence (Ala24-Ser297) of human FCGRT (Accession #NP_004098.1) fused with a 6×His tag at the C-terminus and the s |
| Background | Active Recombinant Human FcRn Protein is produced by HEK293 cells expression system. The target heterodimer proteins are co-expressed with the sequence (Ala24-Ser297) of human FCGRT (Accession #NP_004098.1) fused with a 6×His tag at the C-terminus and the sequence (Ile21-Met119) of human B2M (Accession #NP_004039.1). |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
